Temple University Health System Now Includes Fox Chase Cancer Center
Relationship Strengthens Cancer Care and Research Opportunities
Dr. Larry Kaiser, President and CEO of Temple University Health System (left) and Dr. Michael Seiden, President and CEO of Fox Chase Cancer Center, shake hands after closing on the final agreement that brings Fox Chase Cancer Center into Temple University Health System.
(Philadelphia, PA) – As of July 1, 2012, Fox Chase Cancer Center became a part of Temple University Health System, one of Philadelphia’s leading academic health centers, providing access to quality care through its hospitals and multi-specialty satellite facilities while supporting excellence and innovation in education and research.
“We are pleased to welcome Fox Chase Cancer Center into Temple’s healthcare enterprise,” said Larry R. Kaiser, MD, FACS, Senior Executive Vice President of Health Sciences for Temple University, President & CEO of Temple University Health System, and Dean of Temple University School of Medicine. “The addition of Fox Chase Cancer Center – one of only 41 National Cancer Institute-designated comprehensive cancer centers in the U.S. – solidifies Temple’s position as a leader in cancer care and translational research. It also sets the stage for exciting and numerous opportunities to grow and enhance cancer-related patient care, research and educational programs.”
“Fox Chase Cancer Center is committed to serving as one of the nation’s top comprehensive cancer centers, delivering world-class care to our patients and remaining at the forefront of scientific discovery,” said Michael V. Seiden, MD, PhD, President & CEO of Fox Chase Cancer Center. “Now, as a member of Temple University Health System, we are in a stronger position than ever before to meet the needs of current and future cancer patients.”
Six months ago, on December 15, 2011, Temple University Health System and Fox Chase Cancer Center signed an affiliation agreement for TUHS to acquire Fox Chase Cancer Center.
The newly official relationship between Temple University Health System and Fox Chase Cancer Center also promotes collaborative synergies between and among the physician-scientists at Temple University School of Medicine and Fox Chase Cancer Center – which will accelerate the pace of further discovery and development of the most effective approaches to cancer prevention, diagnosis and treatment. The collaboration between these two highly regarded institutions will enhance their ability to recruit and retain the nation’s best researchers and clinicians, which in turn will help meet the healthcare needs of a growing patient base.
As an affiliate of Temple University Health System, Fox Chase Cancer Center will significantly expand its outpatient and surgical-care services – both within its existing facilities and through the use of leased space in neighboring Jeanes Hospital, an affiliate of Temple University Health System since 1996.
About Temple Health
Temple Health refers to the health, education and research activities carried out by the affiliates of Temple University Health System and Temple University School of Medicine.
Temple University Health System (TUHS) is a $1.4 billion academic health system dedicated to providing access to quality patient care and supporting excellence in medical education and research. The Health System consists of Temple University Hospital (TUH), ranked among the “Best Hospitals” in the region by U.S. News & World Report; TUH-Episcopal Campus; TUH-Northeastern Campus; Fox Chase Cancer Center, an NCI-designated comprehensive cancer center; Jeanes Hospital, a community-based hospital offering medical, surgical and emergency services; Temple Transport Team, a ground and air-ambulance company; and Temple Physicians, Inc., a network of community-based specialty and primary-care physician practices. TUHS is affiliated with Temple University School of Medicine.
Temple University School of Medicine (TUSM), established in 1901, is one of the nation’s leading medical schools. Each year, the School of Medicine educates approximately 720 medical students and 140 graduate students. Based on its level of funding from the National Institutes of Health, Temple University School of Medicine is the second-highest ranked medical school in Philadelphia and the third-highest in the Commonwealth of Pennsylvania. According to U.S. News & World Report, TUSM is among the top 10 most applied-to medical schools in the nation.
Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. For more information, call 1-888-FOX CHASE or (1-888-369-2427).
Media inquiries only, please contact Jeremy Moore at 215-728-2700.